You are viewing the site in preview mode

Skip to main content

Table 3 Unweighted and propensity-score weighted analysis of secondary outcomes

From: Early initiation of ceftaroline-based combination therapy for methicillin-resistant Staphylococcus aureus bacteremia

Outcome

Unadjusted Analysisa

Propensity score-weighted regression

Combination

Monotherapy

OR (95% CI)

Time to microbiological cure, days

4.4 ± 3

2.8 ± 2.4

Mean difference (95% CI)

1.50 (0.60, 2.41)

Hospital length of stay, days

28.8 ± 37.9

17.4 ± 17.9

Mean difference (95% CI)

13.38 (2.43, 24.34)

30-day readmission

33/99 (33)

20/69 (29)

0.74 (0.35, 1.54)

90-day recurrence

4/70 (5.7)

9/97 (9.3)

0.59 (0.51, 2.40)

  1. aData are presented as No. (%) for dichotomous variables and mean ± standard deviation for continuous variables